Wutah pendapatan taun lumaku: telesisbio.com (TBIO)

Strong B2B sector confidence in the precision of Telesis Bio systems is bolstered by the implementation of Digital-to-Biological robotic platforms for autonomous DNA synthesis. The year-over-year trend in core revenue over a rolling 12-month period confirms this status, with the metric holding around 42.50. Such technologies replace routine laboratory labor, allowing scientists to focus on the strategic aspects of biomaterial development.
Telesis Bio Inc. (TBIO) - rincian metrik lan laporan keuangan

This indicator measures revenue dynamics over the trailing twelve months relative to the same period last year, allowing for an assessment of business scaling rates. By analyzing the annual sales volume trend (LTM), an investor can discern the actual expansion efficiency of Telesis Bio, Inc. (TBIO), which is supported by low demand elasticity and the company's high pricing power in the automated DNA synthesis segment.